[1]
M. Mazurek, E. Białowąs, E. Dybała, I. Cuber, and A. Aghadi, “Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis”, J Educ Health Sport, vol. 13, no. 4, pp. 123–131, Feb. 2023.